Skip to main navigation Skip to search Skip to main content

Osteoclast inhibition in postmenopausal breast cancer: Is the evidence too strong to ignore?

Research output: Contribution to journalEditorial

3 Scopus citations
Original languageEnglish
Pages (from-to)2392-2394
Number of pages3
JournalCancer
Volume123
Issue number13
DOIs
StatePublished - Jul 1 2017

Fingerprint

Dive into the research topics of 'Osteoclast inhibition in postmenopausal breast cancer: Is the evidence too strong to ignore?'. Together they form a unique fingerprint.

Cite this